Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001615774-18-013954

Options or other derivatives

  • Chief Financial Officer acquired 26,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
D'Ambrosio Donald Eric Chief Financial Officer 2018-12-03 Grant or award · EMPLOYEE STOCK OPTION (right to purchase) +26,500 26,500 D
Loading xslF345X03/s114542_form4.xml…